Laboratory Of Stock Buy Hold or Sell Recommendation
| LH Stock | USD 242.15 0.00 0.00% |
Allowing for the 90-day total investment horizon and your above-average risk tolerance, our recommendation regarding Laboratory of is 'Hold'. The recommendation algorithm takes into account all of Laboratory's available fundamental, technical, and predictive indicators you will find on this site.
Check out Laboratory Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as Laboratory and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Laboratory of. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
Laboratory |
Execute Laboratory Buy or Sell Advice
The Laboratory recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Laboratory of. Macroaxis does not own or have any residual interests in Laboratory of or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Laboratory's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Hold
Market Performance | Modest | Details | |
Volatility | Very steady | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Very Low | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Strong | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Possible Manipulator | Details |
Laboratory Trading Alerts and Improvement Suggestions
| Laboratory has a strong financial position based on the latest SEC filings | |
| Over 95.0% of the company shares are owned by institutional investors | |
| On 26th of November 2024 Laboratory paid $ 0.72 per share dividend to its current shareholders | |
| Latest headline from gurufocus.com: Insider Sell van der Vaart Sandra D Sells 1,000 Shares of Labcorp Holdings Inc |
Laboratory Returns Distribution Density
The distribution of Laboratory's historical returns is an attempt to chart the uncertainty of Laboratory's future price movements. The chart of the probability distribution of Laboratory daily returns describes the distribution of returns around its average expected value. We use Laboratory of price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Laboratory returns is essential to provide solid investment advice for Laboratory.
| Mean Return | 0.07 | Value At Risk | -1.83 | Potential Upside | 2.10 | Standard Deviation | 1.29 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Laboratory historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Laboratory Stock Institutional Investors
| Shares | Dimensional Fund Advisors, Inc. | 2024-09-30 | 1.4 M | Amvescap Plc. | 2024-06-30 | 1.3 M | Veritas Investment Partners (uk) Ltd. | 2024-09-30 | 1.2 M | Norges Bank | 2024-06-30 | 1 M | Northern Trust Corp | 2024-09-30 | 1 M | Nordea Investment Mgmt Bank Demark A/s | 2024-09-30 | 984 K | Bank Of America Corp | 2024-06-30 | 978.1 K | Cooke & Bieler Lp | 2024-09-30 | 942.1 K | Ubs Asset Mgmt Americas Inc | 2024-09-30 | 914 K | Vanguard Group Inc | 2024-09-30 | 9.6 M | Blackrock Inc | 2024-06-30 | 9.5 M |
Laboratory Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | (89.3M) | 983.3M | 151.9M | (1.0B) | 216.2M | 227.0M | |
| Free Cash Flow | 1.0B | 1.8B | 2.6B | 1.5B | 874.1M | 619.8M | |
| Depreciation | 577.2M | 624.7M | 745.1M | 633.9M | 577.3M | 606.2M | |
| Capital Expenditures | 400.2M | 381.7M | 460.4M | 481.9M | 453.6M | 476.3M | |
| Net Income | 824.9M | 1.6B | 2.4B | 1.3B | 380.4M | 514.7M | |
| End Period Cash Flow | 337.5M | 1.3B | 1.5B | 430M | 536.8M | 295.5M | |
| Dividends Paid | 2.4B | 151.7M | 1B | 195.2M | 254M | 241.3M | |
| Other Non Cash Items | 200.8M | 745.8M | 170.9M | 482.4M | 681.3M | 715.4M | |
| Change To Inventory | (21.9M) | (196.6M) | 2.8M | (45.5M) | (700K) | (735K) | |
| Investments | (1.3B) | (643.2M) | (14.6M) | (1.7B) | (1.1B) | (1.1B) | |
| Net Borrowings | (409.3M) | 210.1M | (412.2M) | (375M) | (337.5M) | (320.6M) | |
| Change To Netincome | 144M | 611.1M | 56M | 646.3M | 743.2M | 780.4M |
Laboratory Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Laboratory or Health Care Providers & Services sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Laboratory's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Laboratory stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.01 | |
β | Beta against Dow Jones | 0.64 | |
σ | Overall volatility | 1.33 | |
Ir | Information ratio | -0.04 |
Laboratory Volatility Alert
Laboratory of has relatively low volatility with skewness of 0.39 and kurtosis of 2.1. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Laboratory's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Laboratory's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Laboratory Fundamentals Vs Peers
Comparing Laboratory's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Laboratory's direct or indirect competition across all of the common fundamentals between Laboratory and the related equities. This way, we can detect undervalued stocks with similar characteristics as Laboratory or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Laboratory's fundamental indicators could also be used in its relative valuation, which is a method of valuing Laboratory by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Laboratory to competition |
| Fundamentals | Laboratory | Peer Average |
| Return On Equity | 0.0543 | -0.31 |
| Return On Asset | 0.0396 | -0.14 |
| Profit Margin | 0.03 % | (1.27) % |
| Operating Margin | 0.08 % | (5.51) % |
| Current Valuation | 26.17 B | 16.62 B |
| Shares Outstanding | 83.64 M | 571.82 M |
| Shares Owned By Insiders | 0.32 % | 10.09 % |
| Shares Owned By Institutions | 94.80 % | 39.21 % |
| Number Of Shares Shorted | 2.23 M | 4.71 M |
| Price To Earning | 12.69 X | 28.72 X |
| Price To Book | 2.44 X | 9.51 X |
| Price To Sales | 1.57 X | 11.42 X |
| Revenue | 12.16 B | 9.43 B |
| Gross Profit | 4.39 B | 27.38 B |
| EBITDA | 1.35 B | 3.9 B |
| Net Income | 380.4 M | 570.98 M |
| Cash And Equivalents | 430 M | 2.7 B |
| Cash Per Share | 4.63 X | 5.01 X |
| Total Debt | 5.95 B | 5.32 B |
| Debt To Equity | 0.63 % | 48.70 % |
| Current Ratio | 1.73 X | 2.16 X |
| Book Value Per Share | 97.61 X | 1.93 K |
| Cash Flow From Operations | 1.33 B | 971.22 M |
| Short Ratio | 2.93 X | 4.00 X |
| Earnings Per Share | 5.28 X | 3.12 X |
| Price To Earnings To Growth | 0.51 X | 4.89 X |
| Target Price | 261.06 | |
| Number Of Employees | 67 K | 18.84 K |
| Beta | 1.04 | -0.15 |
| Market Capitalization | 19.97 B | 19.03 B |
| Total Asset | 16.73 B | 29.47 B |
| Retained Earnings | 7.89 B | 9.33 B |
| Working Capital | 540.2 M | 1.48 B |
Note: Acquisition by Akinbolade Oyegunwa of 1110 shares of Laboratory subject to Rule 16b-3 [view details]
Laboratory Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Laboratory . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 649.84 | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 240.44 | |||
| Day Typical Price | 241.01 | |||
| Market Facilitation Index | 1.0E-4 | |||
| Price Action Indicator | 1.71 | |||
| Relative Strength Index | 77.17 |
About Laboratory Buy or Sell Advice
When is the right time to buy or sell Laboratory of? Buying financial instruments such as Laboratory Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Laboratory in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Theme ETFs Thematic Idea Now
Theme ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Theme ETFs theme has 483 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Theme ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Laboratory Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Laboratory. If investors know Laboratory will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Laboratory listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.05) | Dividend Share 2.88 | Earnings Share 5.28 | Revenue Per Share 151.028 | Quarterly Revenue Growth 0.074 |
The market value of Laboratory is measured differently than its book value, which is the value of Laboratory that is recorded on the company's balance sheet. Investors also form their own opinion of Laboratory's value that differs from its market value or its book value, called intrinsic value, which is Laboratory's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Laboratory's market value can be influenced by many factors that don't directly affect Laboratory's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Laboratory's value and its price as these two are different measures arrived at by different means. Investors typically determine if Laboratory is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Laboratory's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.